Article
Myocilin Predictive Genetic Testing for Primary Open-Angle Glaucoma Leads to Early Identification of At-Risk Individuals.
Ophthalmology - 1 Mar 2017
Souzeau Emmanuelle, Tram Kien Hou, Witney Martin, Ruddle Jonathan B, Graham Stuart L, Healey Paul R, Goldberg Ivan, Mackey David A, Hewitt Alex W, Burdon Kathryn P, Craig Jamie E
Abstract excerpt
PURPOSE: To assess the difference in severity of disease in primary open-angle glaucoma (POAG) patients with a Myocilin (MYOC) disease-causing variant who presented through normal clinical pathways (Clinical cases) versus those who were examined following genetic testing (Genetic cases). DESIGN: Retrospective clinical and molecular study. PARTICIPANTS: Seventy-three MYOC mutation carriers identified through the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
